Cap myopathy

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:171881OMIM:609284G71.2
Who is this for?
Show terms as
26Specialists8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Cap myopathy (also known as cap disease) is an extremely rare congenital myopathy, a subtype of the broader group of nemaline myopathies, classified under ICD-10 code G71.2. It is named after the characteristic 'cap-like' structures found beneath the sarcolemma (muscle cell membrane) on muscle biopsy. These cap structures consist of disorganized myofibrils and thickened Z-disc material that form peripheral, well-demarcated regions within muscle fibers. The disease primarily affects the skeletal muscular system, leading to progressive or nonprogressive muscle weakness. Clinical features typically include generalized muscle weakness and hypotonia, which may be present from birth or early childhood. Patients often exhibit facial weakness, a long face (elongated facies), high-arched palate, and skeletal abnormalities such as scoliosis, scapular winging, and joint contractures. Respiratory insufficiency is a significant concern and can be life-threatening, particularly in severe neonatal presentations. Dysphagia (difficulty swallowing) and feeding difficulties may also occur. The severity of cap myopathy is highly variable, ranging from mild weakness with near-normal function to severe neonatal forms with respiratory failure. Cap myopathy has been associated with mutations in several genes, including TPM2 (beta-tropomyosin), TPM3 (gamma-tropomyosin), and ACTA1 (skeletal muscle alpha-actin). Most reported cases are sporadic, though autosomal dominant inheritance has been documented in some families. There is currently no cure or disease-specific treatment for cap myopathy. Management is supportive and multidisciplinary, including physical therapy to maintain mobility, respiratory support (including non-invasive ventilation when needed), orthopedic interventions for scoliosis and contractures, and nutritional support for those with feeding difficulties. Regular monitoring of respiratory function is essential.

Also known as:

Clinical phenotype terms— hover any for plain English:

Abnormal muscle fiber morphologyHP:0004303Aortic root aneurysmHP:0002616Thoracic scoliosisHP:0002943Easy fatigabilityHP:0003388Generalized amyotrophyHP:0003700
Inheritance

Variable

Can be inherited in different ways depending on the underlying gene

Age of Onset

Variable

Can begin at different ages, from infancy through adulthood

Orphanet ↗OMIM ↗NORD ↗

FDA & Trial Timeline

10 events
Jul 2026Intra-gastrointestinal Monitoring Device (PressureDOT®) and Centurion IAP Monitoring Device Comparison Study: Pivotal Study of Safety and Performance.

Dotspace Inc. — NA

TrialNOT YET RECRUITING
Jun 2026Pharmacokinetics, Pharmacodynamics, Safety and Tolerability Evaluation of CTAP101 Extended-release Capsules in Pediatric Participants

OPKO Health, Inc. — PHASE2

TrialNOT YET RECRUITING
Jan 2026Deep Brain Stimulation of the Anterior Cingulate Bundle (ACB) and the Ventral Anterior Limb of the Internal Capsule (vALIC) in Patients With Intractable Obsessive Compulsive Disorder (OCD)

Rhode Island Hospital — NA

TrialNOT YET RECRUITING
Jan 2026Heart Failure Center Accreditation in China (HF-CAP Trial)

Shanghai Zhongshan Hospital — NA

TrialNOT YET RECRUITING
Jan 2026Continuous Observational Monitoring Program for Allay™ Hydrogel Cap Safety and Success Study

Tulavi Therapeutics,Inc.

TrialNOT YET RECRUITING
Nov 2025A Clinical Study Evaluating the Efficacy and Safety of CreNeuriS CNS Herbal Nutrition Capsules for Participants With Mild Depressive Disorder Comorbid With Anxiety Disorder

Second Affiliated Hospital of Nanchang University — NA

TrialACTIVE NOT RECRUITING
Sep 2025A Study to Monitor the Fruzaqla Treatment of Adults With Metastatic Colorectal Cancer (mCRC) in South Korea

Takeda

TrialRECRUITING
Sep 2025Clinical Study to Compare Efficacy and Safety of Indinol Forto® 200 mg Capsules and Visanne 2 mg Tablets in Treatment of Endometriosis

Alcea — PHASE3

TrialRECRUITING
Sep 2025Faecal Autologous Capsule Transplantation for Type 1 Diabetes Mellitus

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) — PHASE2

TrialRECRUITING
Sep 2025VC/VS for Apathy in PD

Nora Vanegas — NA

TrialNOT YET RECRUITING

Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Treatments

No FDA-approved treatments are currently listed for Cap myopathy.

View clinical trials →

No actively recruiting trials found for Cap myopathy at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Cap myopathy community →

Specialists

Showing 25 of 26View all specialists →
HM
Hugh J McMillan
BURLINGTON, MA
Specialist
1 Cap myopathy publication
MB
Mainak Bardhan
Specialist
1 Cap myopathy publication
RA
Ram Murthy Anjanappa
Specialist
1 Cap myopathy publication
SV
Seena Vengalil
Specialist
1 Cap myopathy publication
VP
Veeramani Preethish-Kumar
Specialist
1 Cap myopathy publication
KP
Kiran Polavarapu
BURLESON, TX
Specialist
1 Cap myopathy publication
LS
Leena Shingavi
Specialist
1 Cap myopathy publication
TC
Tanushree Chawla
Specialist
1 Cap myopathy publication
SN
Saraswati Nashi
Specialist
1 Cap myopathy publication
DM
Dhaarini Mohan
Specialist
1 Cap myopathy publication
GA
Gautham Arunachal
Specialist
1 Cap myopathy publication
AN
Atchayaram Nalini
Specialist
1 Cap myopathy publication
AM
Aren E Marshall
Specialist
1 Cap myopathy publication
AM
Alain LACHAUX, MD
Specialist
PI on 2 active trials
SP
Stanislaw R. Burzynski, MD, PhD
HOUSTON, TX
Specialist
PI on 29 active trials
YP
Yanyan Liu, M.D. Ph.D
Specialist
PI on 3 active trials
YS
Yuankai Shi
Specialist
PI on 5 active trials256 Cap myopathy publications
UC
Use Central Contact
Specialist
PI on 28 active trials
SM
Shigeru Yoshida, MD
Specialist
PI on 3 active trials
TG
Thenral S Geetha
Specialist
1 Cap myopathy publication
VR
Vedam Ramprasad
Specialist
1 Cap myopathy publication
RS
Renato R Soliaman
Specialist
PI on 1 active trial

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Cap myopathy.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Cap myopathyForum →

No community posts yet. Be the first to share your experience with Cap myopathy.

Start the conversation →

Latest news about Cap myopathy

Disease timeline:

New recruiting trial: Evaluation of the Efficacy and Safety of AL2846 Capsule Combined With TQB2450 Injection Compared to Docetaxel Injection in Advanced Non-small Cell Lung Cancer Patients Who Have Failed With Immunotherapy.

A new clinical trial is recruiting patients for Cap myopathy

New recruiting trial: Fufang Congrong Yizhi Capsules (FCYC) of Cognitive Impairment After Intracerebral Hemorrhage

A new clinical trial is recruiting patients for Cap myopathy

New recruiting trial: Clinical Trial With MBK-01, Intestinal Microbiota Capsules, for the Treatment of Patients With Recurrent Diverticulitis

A new clinical trial is recruiting patients for Cap myopathy

New recruiting trial: Clinical Study to Compare Efficacy and Safety of Indinol Forto® 200 mg Capsules and Visanne 2 mg Tablets in Treatment of Endometriosis

A new clinical trial is recruiting patients for Cap myopathy

New recruiting trial: Connectomic Deep Brain Stimulation for Obsessive Compulsive Disorder

A new clinical trial is recruiting patients for Cap myopathy

New recruiting trial: Modified VR-CAP and Acalabrutinib as First Line Therapy for the Treatment of Transplant-Eligible Patients With Mantle Cell Lymphoma

A new clinical trial is recruiting patients for Cap myopathy

New recruiting trial: Study to Evaluate Sutetinib Maleate Capsule in Locally Advanced or Metastatic Non-small Cell Lung Cancer

A new clinical trial is recruiting patients for Cap myopathy

New recruiting trial: Comparison of Effectiveness of TissuePatchTM in Preventing Postoperative Pancreatic Fistula

A new clinical trial is recruiting patients for Cap myopathy

New recruiting trial: Feasibility of a Minimally Invasive Diagnostic Algorithm in Suspected Crohn's Disease

A new clinical trial is recruiting patients for Cap myopathy

New recruiting trial: PillSense for Suspected Upper Gastrointestinal Bleeding

A new clinical trial is recruiting patients for Cap myopathy

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Cap myopathy

What is Cap myopathy?

Cap myopathy (also known as cap disease) is an extremely rare congenital myopathy, a subtype of the broader group of nemaline myopathies, classified under ICD-10 code G71.2. It is named after the characteristic 'cap-like' structures found beneath the sarcolemma (muscle cell membrane) on muscle biopsy. These cap structures consist of disorganized myofibrils and thickened Z-disc material that form peripheral, well-demarcated regions within muscle fibers. The disease primarily affects the skeletal muscular system, leading to progressive or nonprogressive muscle weakness. Clinical features typica

Which specialists treat Cap myopathy?

25 specialists and care centers treating Cap myopathy are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.